470 related articles for article (PubMed ID: 15837258)
21. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
22. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment.
Ball W; Ivanov J; Rakowski H; Wigle ED; Linghorne M; Ralph-Edwards A; Williams WG; Schwartz L; Guttman A; Woo A
J Am Coll Cardiol; 2011 Nov; 58(22):2313-21. PubMed ID: 22093509
[TBL] [Abstract][Full Text] [Related]
24. Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU setting.
Sirak TE; Sherrid MV
Chest; 2008 May; 133(5):1243-6. PubMed ID: 18460523
[TBL] [Abstract][Full Text] [Related]
25. Markers of responsiveness to disopyramide in patients with hypertrophic cardiomyopathy.
Habib M; Hoss S; Bruchal-Garbicz B; Chan RH; Rakowski H; Williams L; Adler A
Int J Cardiol; 2019 Dec; 297():75-82. PubMed ID: 31615649
[TBL] [Abstract][Full Text] [Related]
26. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
[TBL] [Abstract][Full Text] [Related]
27. Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy.
Melacini P; Maron BJ; Bobbo F; Basso C; Tokajuk B; Zucchetto M; Thiene G; Iliceto S
Heart; 2007 Jun; 93(6):708-10. PubMed ID: 17502652
[TBL] [Abstract][Full Text] [Related]
28. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
Elliott PM; Gimeno JR; Tomé MT; Shah J; Ward D; Thaman R; Mogensen J; McKenna WJ
Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
[TBL] [Abstract][Full Text] [Related]
29. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Sorajja P; Ommen SR; Holmes DR; Dearani JA; Rihal CS; Gersh BJ; Lennon RJ; Nishimura RA
Circulation; 2012 Nov; 126(20):2374-80. PubMed ID: 23076968
[TBL] [Abstract][Full Text] [Related]
30. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
[TBL] [Abstract][Full Text] [Related]
31. Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy.
Ostman-Smith I; Wettrell G; Keeton B; Holmgren D; Ergander U; Gould S; Bowker C; Verdicchio M
Eur Heart J; 2008 May; 29(9):1160-7. PubMed ID: 18385119
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy.
Olivotto I; Montereggi A; Mazzuoli F; Cecchi F
G Ital Cardiol; 1999 Jan; 29(1):11-9. PubMed ID: 9987042
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy.
Vriesendorp PA; Liebregts M; Steggerda RC; Schinkel AF; Willems R; Ten Cate FJ; van Cleemput J; Ten Berg JM; Michels M
JACC Heart Fail; 2014 Dec; 2(6):630-6. PubMed ID: 25447346
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy.
Thaman R; Gimeno JR; Murphy RT; Kubo T; Sachdev B; Mogensen J; Elliott PM; McKenna WJ
Heart; 2005 Jul; 91(7):920-5. PubMed ID: 15958362
[TBL] [Abstract][Full Text] [Related]
35. [Interventional treatment in hypertrophic cardiomyopathy].
Gietzen FH; Schümmelfeder J; Neuser H; Brunn J; Schumacher B; Kerber S
Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098
[TBL] [Abstract][Full Text] [Related]
36. Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report.
Haruki S; Minami Y; Kajimoto K; Yashiro B; Suzuki T; Kawana M; Hagiwara N
Eur J Heart Fail; 2010 Jan; 12(1):94-7. PubMed ID: 19942605
[TBL] [Abstract][Full Text] [Related]
37. Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients.
Adler A; Fourey D; Weissler-Snir A; Hindieh W; Chan RH; Gollob MH; Rakowski H
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28550094
[TBL] [Abstract][Full Text] [Related]
38. Cardiac pacing in hypertrophic cardiomyopathy: a cohort with 24 years of follow-up.
Silva LA; Fernández EA; Martinelli Filho M; Costa R; Siqueira S; Ianni BM; Mady C
Arq Bras Cardiol; 2008 Oct; 91(4):250-6, 274-80. PubMed ID: 19009178
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.
van der Lee C; ten Cate FJ; Geleijnse ML; Kofflard MJ; Pedone C; van Herwerden LA; Biagini E; Vletter WB; Serruys PW
Circulation; 2005 Jul; 112(4):482-8. PubMed ID: 16027255
[TBL] [Abstract][Full Text] [Related]
40. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging.
Kwon DH; Smedira NG; Popovic ZB; Lytle BW; Setser RM; Thamilarasan M; Schoenhagen P; Flamm SD; Lever HM; Desai MY
Heart; 2009 Nov; 95(21):1784-91. PubMed ID: 19549621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
